Related references
Note: Only part of the references are listed.A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
Marc Michel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Autoimmune Hemolytic Anemia
Howard A. Liebman et al.
MEDICAL CLINICS OF NORTH AMERICA (2017)
The BAFFling effects of rituximab in lupus: danger ahead?
Michael R. Ehrenstein et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Off-label use of rituximab for systemic lupus erythematosus in Europe
Monica Ryden-Aulin et al.
LUPUS SCIENCE & MEDICINE (2016)
Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies
Mehdi Khellaf et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
Efficacy and safety of laparoscopic splenectomy in thrombocytopenia secondary to systemic lupus erythematosus
Jin Zhou et al.
CLINICAL RHEUMATOLOGY (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Safety and Efficacy of Rituximab in Systemic Lupus Erythematosus
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases
Guillaume Bussone et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases
Marc Michel et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Platelet autoantibodies and lupus-associated thrombocytopenia
M Michel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)